REFILE-UPDATE 1-Teva gets FDA approval for generic antideprssant

(Refiles to add UPDATE 1 tag to headline, with no changes to text)

JERUSALEM, June 29 (Reuters) - Israeli drugmaker Teva Pharmaceutical Industries (TEVA.TA) TEVA.O said on Tuesday it had received U.S. Food and Drug Administration approval for a generic version of Wyeth's antidepressant drug Effexor XR.

Shipments for the drug -- Venlafaxine Hcl ER -- were expected to start on July 1, as per a 2006 agreement with Wyeth, a unit of Pfizer (PFE.N), Teva said.

Effexor has annual sales in the United States of $2.75 billion, based on IMS data. [ID:nWNAB1646]

As the first company to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity. (Reporting by Steven Scheer; Editing by Dan Lalor)